Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes

Ran Choi, Bo Hwan Kim, Jarinyaporn Naowaboot, Mi Young Lee, Mi Ri Hyun, Eun Ju Cho, Eun Soo Lee, Eun Young Lee, Young Chul Yang, Choon Hee Chung

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Diabetic nephropathy is the most serious complication in diabetes mellitus. It is known that oxidative stress and inflammation play a central role in the development of diabetic nephropathy. In this study, we investigated that ferulic acid (FA) known as anti-oxidative agent could effect on diabetic nephropathy by anti-oxidative and anti-inflammatory mechanism. We examined the effects of FA in obese diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats and non-diabetic control Long-Evans Tokushima Otsuka (LETO) rats. We treated FA to experimental rats from 26 to 45 weeks of age. We evaluated ACR, MDA and MCP-1 in 24 h urine and examined renal histopathology and morphologic change in extracted kidneys from rats. Also, we evaluated the ROS production and MCP-1 levels in cultured podocyte after FA treatment. In the FA-treated OLETF rats, blood glucose was significantly decreased and serum adiponectin levels were increased. Urinary ACR was significantly reduced in FA-treated OLETF rats compared with diabetic OLETF rats. In renal histopathology, FA-treated OLETF rats showed decreased glomerular basement membrane thickness, glomerular volume, and mesangial matrix expansion. FA treatment decreased oxidative stress markers and MCP-1 levels in 24 h urine of rats and supernatants of cultured podocyte. In conclusion, it was suggested that FA have protective and therapeutic effects on diabetic nephropathy by reducing oxidative stress and inflammation.

Original languageEnglish
Pages (from-to)676-683
Number of pages8
JournalExperimental and Molecular Medicine
Volume43
Issue number12
DOIs
Publication statusPublished - 2011 Dec 31

Fingerprint

ferulic acid
Diabetic Nephropathies
Medical problems
Inbred OLETF Rats
Type 2 Diabetes Mellitus
Rats
Oxidative stress
Podocytes
Oxidative Stress
Kidney
Urine
Inflammation
Glomerular Basement Membrane
Adiponectin

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Choi, Ran ; Kim, Bo Hwan ; Naowaboot, Jarinyaporn ; Lee, Mi Young ; Hyun, Mi Ri ; Cho, Eun Ju ; Lee, Eun Soo ; Lee, Eun Young ; Yang, Young Chul ; Chung, Choon Hee. / Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. In: Experimental and Molecular Medicine. 2011 ; Vol. 43, No. 12. pp. 676-683.
@article{8975ca70158c4a82a3bbdf153802d695,
title = "Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes",
abstract = "Diabetic nephropathy is the most serious complication in diabetes mellitus. It is known that oxidative stress and inflammation play a central role in the development of diabetic nephropathy. In this study, we investigated that ferulic acid (FA) known as anti-oxidative agent could effect on diabetic nephropathy by anti-oxidative and anti-inflammatory mechanism. We examined the effects of FA in obese diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats and non-diabetic control Long-Evans Tokushima Otsuka (LETO) rats. We treated FA to experimental rats from 26 to 45 weeks of age. We evaluated ACR, MDA and MCP-1 in 24 h urine and examined renal histopathology and morphologic change in extracted kidneys from rats. Also, we evaluated the ROS production and MCP-1 levels in cultured podocyte after FA treatment. In the FA-treated OLETF rats, blood glucose was significantly decreased and serum adiponectin levels were increased. Urinary ACR was significantly reduced in FA-treated OLETF rats compared with diabetic OLETF rats. In renal histopathology, FA-treated OLETF rats showed decreased glomerular basement membrane thickness, glomerular volume, and mesangial matrix expansion. FA treatment decreased oxidative stress markers and MCP-1 levels in 24 h urine of rats and supernatants of cultured podocyte. In conclusion, it was suggested that FA have protective and therapeutic effects on diabetic nephropathy by reducing oxidative stress and inflammation.",
author = "Ran Choi and Kim, {Bo Hwan} and Jarinyaporn Naowaboot and Lee, {Mi Young} and Hyun, {Mi Ri} and Cho, {Eun Ju} and Lee, {Eun Soo} and Lee, {Eun Young} and Yang, {Young Chul} and Chung, {Choon Hee}",
year = "2011",
month = "12",
day = "31",
doi = "10.3858/emm.2011.43.12.078",
language = "English",
volume = "43",
pages = "676--683",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "12",

}

Choi, R, Kim, BH, Naowaboot, J, Lee, MY, Hyun, MR, Cho, EJ, Lee, ES, Lee, EY, Yang, YC & Chung, CH 2011, 'Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes', Experimental and Molecular Medicine, vol. 43, no. 12, pp. 676-683. https://doi.org/10.3858/emm.2011.43.12.078

Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. / Choi, Ran; Kim, Bo Hwan; Naowaboot, Jarinyaporn; Lee, Mi Young; Hyun, Mi Ri; Cho, Eun Ju; Lee, Eun Soo; Lee, Eun Young; Yang, Young Chul; Chung, Choon Hee.

In: Experimental and Molecular Medicine, Vol. 43, No. 12, 31.12.2011, p. 676-683.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes

AU - Choi, Ran

AU - Kim, Bo Hwan

AU - Naowaboot, Jarinyaporn

AU - Lee, Mi Young

AU - Hyun, Mi Ri

AU - Cho, Eun Ju

AU - Lee, Eun Soo

AU - Lee, Eun Young

AU - Yang, Young Chul

AU - Chung, Choon Hee

PY - 2011/12/31

Y1 - 2011/12/31

N2 - Diabetic nephropathy is the most serious complication in diabetes mellitus. It is known that oxidative stress and inflammation play a central role in the development of diabetic nephropathy. In this study, we investigated that ferulic acid (FA) known as anti-oxidative agent could effect on diabetic nephropathy by anti-oxidative and anti-inflammatory mechanism. We examined the effects of FA in obese diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats and non-diabetic control Long-Evans Tokushima Otsuka (LETO) rats. We treated FA to experimental rats from 26 to 45 weeks of age. We evaluated ACR, MDA and MCP-1 in 24 h urine and examined renal histopathology and morphologic change in extracted kidneys from rats. Also, we evaluated the ROS production and MCP-1 levels in cultured podocyte after FA treatment. In the FA-treated OLETF rats, blood glucose was significantly decreased and serum adiponectin levels were increased. Urinary ACR was significantly reduced in FA-treated OLETF rats compared with diabetic OLETF rats. In renal histopathology, FA-treated OLETF rats showed decreased glomerular basement membrane thickness, glomerular volume, and mesangial matrix expansion. FA treatment decreased oxidative stress markers and MCP-1 levels in 24 h urine of rats and supernatants of cultured podocyte. In conclusion, it was suggested that FA have protective and therapeutic effects on diabetic nephropathy by reducing oxidative stress and inflammation.

AB - Diabetic nephropathy is the most serious complication in diabetes mellitus. It is known that oxidative stress and inflammation play a central role in the development of diabetic nephropathy. In this study, we investigated that ferulic acid (FA) known as anti-oxidative agent could effect on diabetic nephropathy by anti-oxidative and anti-inflammatory mechanism. We examined the effects of FA in obese diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats and non-diabetic control Long-Evans Tokushima Otsuka (LETO) rats. We treated FA to experimental rats from 26 to 45 weeks of age. We evaluated ACR, MDA and MCP-1 in 24 h urine and examined renal histopathology and morphologic change in extracted kidneys from rats. Also, we evaluated the ROS production and MCP-1 levels in cultured podocyte after FA treatment. In the FA-treated OLETF rats, blood glucose was significantly decreased and serum adiponectin levels were increased. Urinary ACR was significantly reduced in FA-treated OLETF rats compared with diabetic OLETF rats. In renal histopathology, FA-treated OLETF rats showed decreased glomerular basement membrane thickness, glomerular volume, and mesangial matrix expansion. FA treatment decreased oxidative stress markers and MCP-1 levels in 24 h urine of rats and supernatants of cultured podocyte. In conclusion, it was suggested that FA have protective and therapeutic effects on diabetic nephropathy by reducing oxidative stress and inflammation.

UR - http://www.scopus.com/inward/record.url?scp=84855181872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855181872&partnerID=8YFLogxK

U2 - 10.3858/emm.2011.43.12.078

DO - 10.3858/emm.2011.43.12.078

M3 - Article

VL - 43

SP - 676

EP - 683

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 12

ER -